ARTICLE | Clinical News
Jalyn dutasteride/tamsulosin regulatory update
June 21, 2010 7:00 AM UTC
FDA approved an NDA from GlaxoSmithKline for Jalyn dutasteride/tamsulosin to treat symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. The company expects to launch the fi...